Swiss Market Report
September 28, 2018 / 9:18 PM / 8 months ago

BRIEF-FDA Approves Genentech's Xolair Prefilled Syringe Formulation

1 Min Read

Sept 28 (Reuters) - Roche Holding AG:

* FDA APPROVES GENENTECH’S XOLAIR (OMALIZUMAB) PREFILLED SYRINGE FORMULATION

* GENENTECH SAYS NEW XOLAIR PFS FORMULATION IS EXPECTED TO BE AVAILABLE BY END OF THIS YEAR IN U.S Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below